Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Leukemia, Plasma Cell × High-Throughput Screening Assays × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1

Conditions

Multiple Myeloma 1 Leukemia, Plasma Cell 1

Interventions

sargramostim 1 montanide ISA 51 1 itacitinib 1 incomplete Freund's adjuvant 1 Lenalidomide 1 High-Throughput Screening Assays 1 Colony-Stimulating Factors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03389347 2025-09-22

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

University of Washington

Phase NA Active not recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡